Back to Search
LARRY JUNCK, MD
MD
Neurology Physician
NPI: 1245320399Individual
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
4301045802(MI)
Research & Publications (20)
Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme.
PMID 18834673·Int J Radiat Oncol Biol Phys·2009
3-trial
Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for prediction of radiation-induced neurocognitive dysfunction.
PMID 19223506·Clin Cancer Res·2009
8-other
Developing a clinical decision model: MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast-enhancing lesions.
PMID 19155380·AJR Am J Roentgenol·2009
8-other
Metabolic alterations: a biomarker for radiation-induced normal brain injury-an MR spectroscopy study.
PMID 19161192·J Magn Reson Imaging·2009
8-other
A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05).
PMID 18797818·J Neurooncol·2009
3-trial
A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomas.
PMID 18850068·J Neurooncol·2009
3-trial
The parametric response map is an imaging biomarker for early cancer treatment outcome.
PMID 19377487·Nat Med·2009
8-other
Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography.
PMID 18632004·Alzheimers Dement·2008
8-other
Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas.
PMID 18356283·Neuro Oncol·2008
8-other
Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium study.
PMID 17694310·Cancer Chemother Pharmacol·2008
3-trial
Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival.
PMID 18541899·J Clin Oncol·2008
8-other
Prolonged survival after multifocal brain radiation necrosis associated with whole brain radiation for brain metastases: case report.
PMID 18574669·J Neurooncol·2008
5-case
Predicting outcome of patients with high-grade gliomas after radiotherapy using quantitative analysis of T1-weighted magnetic resonance imaging.
PMID 17276619·Int J Radiat Oncol Biol Phys·2007
8-other
Quantitative characterization of hemodynamic properties and vasculature dysfunction of high-grade gliomas.
PMID 17221937·NMR Biomed·2007
8-other
Phase I study of temozolomide and irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: a north american brain tumor consortium study.
PMID 18056194·Clin Cancer Res·2007
3-trial
Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.
PMID 16877733·J Clin Oncol·2006
3-trial
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.
PMID 16914578·Clin Cancer Res·2006
3-trial
The extent and severity of vascular leakage as evidence of tumor aggressiveness in high-grade gliomas.
PMID 16951209·Cancer Res·2006
8-other
PET measurement of cardiac and nigrostriatal denervation in Parkinsonian syndromes.
PMID 17079809·J Nucl Med·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1500 E MEDICAL CENTER DR
ANN ARBOR, MI 48109 - Phone
- (734) 936-4000
Quick Facts
- NPI
- 1245320399
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile